Adding rasagiline to treatment regimen may help those with Parkinson's, study finds

A recent study finds that the addition of rasagiline (marketed as Azilect) to the treatment regimen of individuals with Parkinson’s disease significantly enhances clinical outcomes. The https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-023-03411-3 was published on [...]